Uploaded August 2016 | Updated September 2026, 1 week ago
A new multimillion pound study, which will see the most thorough and rigorous series of tests to detect Alzheimer’s disease ever performed on volunteers, has been announced. The Deep and Frequent Phenotyping study is funded by the National Institute for Health Research (NIHR) and the Medical Research Council (MRC) and hopes to dramatically improve the success rate of clinical trials for treatments into Alzheimer’s disease.
Here, Trial's manager, Jennifer Lawson, describes the many tests being used.
News story: mrc.io/2b6i7OH
A new multimillion pound study, which will see the most thorough and rigorous series of tests to detect Alzheimer’s disease ever performed on volunteers, has been announced. The Deep and Frequent Phenotyping study is funded by the National Institute for Health Research (NIHR) and the Medical Research Council (MRC) and hopes to dramatically improve the success rate of clinical trials for treatments into Alzheimer’s disease.
Here, Trial's manager, Jennifer Lawson, describes the many tests being used.
News story: mrc.io/2b6i7OH
